GH
BPMC

GAM Holding’s Blueprint Medicines BPMC Stock Holding History

GAM Holding’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,390
Closed -$2.17M – 281
2020
Q3 		$2.17M Hold
23,390
– – 0.13% 200
2020
Q2 		$1.82M Sell
23,390
-15,549
-40% -$1.05M 0.11% 206
2020
Q1 		$2.28M Hold
38,939
– – 0.15% 174
2019
Q4 		$3.12M Hold
38,939
– – 0.15% 188
2019
Q3 		$2.86M Sell
38,939
-6,900
-15% -$596K 0.13% 186
2019
Q2 		$4.32M Sell
45,839
-3,000
-6% -$248K 0.17% 137
2019
Q1 		$3.91M Sell
48,839
-11,661
-19% -$862K 0.16% 151
2018
Q4 		$3.26M Sell
60,500
-7,300
-11% -$444K 0.17% 144
2018
Q3 		$5.29M Buy
67,800
+26,300
+63% +$1.83M 0.19% 139
2018
Q2 		$2.63M Buy
41,500
+26,800
+182% +$2.13M 0.09% 236
2018
Q1 		$1.35M Buy
+14,700
New +$1.27M 0.05% 379

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

GAM Holding's BPMC Position: Q4 2020 in Review

GAM Holding sold out of Blueprint Medicines (BPMC) in Q4 2020, closing a stake of 23,390 shares — an estimated $2.17M sold.

GAM Holding first reported a position in BPMC in Q1 2018 and held it in 11 quarters. The position peaked at $5.29M in Q3 2018. 278 funds tracked by Wall St. Rank hold BPMC as of Q4 2020.

  • GAM Holding reported no remaining Blueprint Medicines position as of Q4 2020 after selling out during the quarter.
  • GAM Holding sold 23,390 Blueprint Medicines shares in Q4 2020, an estimated $2.17M.
  • GAM Holding first reported a position in Blueprint Medicines in Q1 2018 and held it in 11 quarters.
  • GAM Holding's Blueprint Medicines position peaked at $5.29M in Q3 2018.
  • 278 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2020.

Based on GAM Holding's 13F filing for Q4 2020, filed 10 Feb 2021.